RUNX3 and cancer: Given that Mdm4 is known to bind and sequester p53 [23], and that the overexpression of Mdm4 is exploited by several cancers to deregulate p53 function [24-26], the high level of Mdm4 is a likely candidate responsible for the high basal p53 in AML2.